Polycystic kidney disease differentiating polycystic kidney disease from other diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 50: Line 50:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Segmental sclerosis
* Vascular sclerosis
* Interstitial fibrosis
* Tubular atrophy
| style="background: #F5F5F5; padding: 5px;" |Ultrasound
| style="background: #F5F5F5; padding: 5px;" |Ultrasound
| style="background: #F5F5F5; padding: 5px;" |Extrarenal manifestations:
| style="background: #F5F5F5; padding: 5px;" |Extrarenal manifestations:
Line 91: Line 95:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Negative family history of renal cystic disease
* Negative family history of renal cystic disease
Line 138: Line 142:
* White matter lesions
* White matter lesions
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Seizures
* Seizures
Line 160: Line 164:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Clear cell abnormalities
* Clear cell abnormalities
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Retinal hemangioma
* Retinal hemangioma

Revision as of 21:16, 6 June 2018

Polycystic kidney disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic kidney disease from other Diseases

Epidemiology and Demographics

Risk Factor

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Polycystic kidney disease differentiating polycystic kidney disease from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic kidney disease differentiating polycystic kidney disease from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic kidney disease differentiating polycystic kidney disease from other diseases

CDC on Polycystic kidney disease differentiating polycystic kidney disease from other diseases

Polycystic kidney disease differentiating polycystic kidney disease from other diseases in the news

Blogs on Polycystic kidney disease differentiating polycystic kidney disease from other diseases

Directions to Hospitals Treating Polycystic kidney disease

Risk calculators and risk factors for Polycystic kidney disease differentiating polycystic kidney disease from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2] Aarti Narayan, M.B.B.S [3]

Overview

Several cystic diseases can have features of ADPKD namely autosomal recessive polycystic kidney disease (ARPKD, simple renal cysts, autosomal dominant polycystic liver disease, medullary cystic kidney disease and tuberous sclerosis complex.

Differentiating Polycystic kidney disease from other Diseases

  • Autosomal dominant and autosomal recessive polycystic kidney disease must be differentiated from other diseases that cause renal cysts, such as simple renal cysts, medullary sponge kidney, tuberous sclerosis complex, von hippel-lindau disease.

Preferred Table

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Flank/abdominal pain Polyuria Hematuria Hepatomegaly Bilateral flank masses Hypertension Urinalysis Ultrasound CT scan
Autosomal dominant polycystic kidney disease (ADPKD)[1] + + + + + +
  • microalbuminuria
  • proteinuria
  • Bilateral fluid filled cysts
  • Ultrasonography of parents will show cysts
  • Segmental sclerosis
  • Vascular sclerosis
  • Interstitial fibrosis
  • Tubular atrophy
Ultrasound Extrarenal manifestations:
  • Hepatic cysts
  • Pancreatic cysts
Autosomal recessive polycystic kidney disease (ARPKD)[2] + + + + + +
  • microalbuminuria
  • proteinuria
Ultrasonography of parents will not show cysts Ultrasound Extrarenal manifestations:
  • Portal fibrosis
  • Portal hypertension
  • Ascending cholangitis
  • Biliary dysgenesis
  • Pulmonary hypoplasia in neonates
Simple renal cyst[3] - - - - + - -
  • Normal sized kidneys
  • Smooth contour
-
  • Negative family history of renal cystic disease
  • Age ≥ 30 yrs
Medullary sponge kidney[4][5] + +/- + - + -
  • microalbuminuria
  • proteinuria
  • Malformation of distal collecting tubules
  • Nephrolithiasis
  • Nephrolithiasis
  • Renal cortex is spared
  • Medullary nephrocalcinosis
  • Segmental or diffused papillary malformation
  • Enlarged medullary collecting ducts
-
  • Tubular acidosis
  • Recurrent urinary tract infections
Tuberous sclerosis complex[6][7] +/- +/- +/- - + - -
  • Renal cysts
  • Renal angiomyolipomas
  • CT kidneys will differentiate cystic and solid lesions, as well as renal angiomyolipomas
  • CT brain shows:
  • Cortical hemartomas
  • White matter lesions
-
  • Seizures
  • Mental retardation
  • Angiofibroma (face)
  • Shagreen patch
Von Hippel-Lindau disease[8][9] +/- +/- +/- - + - -
  • Renal cysts
  • Clear cell abnormalities
-
  • Retinal hemangioma
  • Clear cell renal cell carcinoma
  • Cerebellar and spinal hemangioblastoma
  • Pheochromocytoma
  • Pancreatic tumor

References

  1. Gabow PA (July 1993). "Autosomal dominant polycystic kidney disease". N. Engl. J. Med. 329 (5): 332–42. doi:10.1056/NEJM199307293290508. PMID 8321262.
  2. Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC (January 2006). "Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)". Medicine (Baltimore). 85 (1): 1–21. doi:10.1097/01.md.0000200165.90373.9a. PMID 16523049.
  3. Ravine D, Gibson RN, Donlan J, Sheffield LJ (December 1993). "An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases". Am. J. Kidney Dis. 22 (6): 803–7. PMID 8250026.
  4. Gambaro G, Feltrin GP, Lupo A, Bonfante L, D'Angelo A, Antonello A (February 2006). "Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s". Kidney Int. 69 (4): 663–70. doi:10.1038/sj.ki.5000035. PMID 16395272.
  5. Levine E, Hartman DS, Meilstrup JW, Van Slyke MA, Edgar KA, Barth JC (August 1997). "Current concepts and controversies in imaging of renal cystic diseases". Urol. Clin. North Am. 24 (3): 523–43. PMID 9275977.
  6. Umeoka S, Koyama T, Miki Y, Akai M, Tsutsui K, Togashi K (2008). "Pictorial review of tuberous sclerosis in various organs". Radiographics. 28 (7): e32. doi:10.1148/rg.e32. PMID 18772274.
  7. Manoukian SB, Kowal DJ (May 2015). "Comprehensive imaging manifestations of tuberous sclerosis". AJR Am J Roentgenol. 204 (5): 933–43. doi:10.2214/AJR.13.12235. PMID 25905927.
  8. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (November 1990). "Clinical features and natural history of von Hippel-Lindau disease". Q. J. Med. 77 (283): 1151–63. PMID 2274658.
  9. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (June 2003). "von Hippel-Lindau disease". Lancet. 361 (9374): 2059–67. doi:10.1016/S0140-6736(03)13643-4. PMID 12814730.

Template:WH Template:WS